TIDMEAH

2 April 2019

ECO Animal Health Group plc

(AIM: EAH)

ECO RECEIVES EUROPEAN MARKETING AUTHORISATION FOR AIVLOSIN® FOR BREEDING CHICKENS

ECO Animal Health Group plc (the "Group") is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a marketing authorisation from the European Medicines Agency (EMA) for the use of Aivlosin® 625 mg/g Water Soluble Granules (WSG) in breeding chickens.

This approval allows ECO to market Aivlosin® 625 mg/g WSG in Europe for the treatment and metaphylaxis of respiratory infections caused by Mycoplasma gallisepticum in breeding chickens producing eggs, for hatching broiler stock and for replacement layers.

Aivlosin®, ECO's patented antimicrobial, is used under veterinary prescription for the treatment of a variety of economically important respiratory and enteric (gut) diseases in poultry and pigs.

Marc Loomes, CEO, commented: "The EU has five per cent of the world's layer and ten per cent of the world's broiler parent stock. This marketing authorisation is very significant as it provides an opportunity to roll out the approval beyond the EU into the multi-million dollar large international poultry markets. This will enable ECO to capitalise on the considerable global potential for Aivlosin® which offers a safe and highly effective medication for Mycoplasma infections in high value breeding birds".

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

ECO Animal Health Group plc

 
Marc Loomes                                       020 8447 6906 
Spiro Financial 
Anthony Spiro                                     020 8336 6196 
IFC Advisory Ltd                                  0203 934 6630 
Graham Herring, Miles Nolan 
N+1 Singer (Nominated Adviser and Joint Broker)   020 7496 3000 
Mark Taylor, James White, Brough Ransom 
Peel Hunt LLP (Joint Broker) 
James Steel, Dr Christopher Golden                020 7418 8900

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders

View source version on businesswire.com: https://www.businesswire.com/news/home/20190401005683/en/

 
This information is provided by Business Wire

(END) Dow Jones Newswires

April 02, 2019 02:00 ET (06:00 GMT)

Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Eco Animal Health Charts.
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Eco Animal Health Charts.